**Question:** Features of tumor lysis syndrome are:

A. Hyperuricemia
B. Hyperkalemia
C. Hypocalcemia
D. Hyperphosphatemia

**Core Concept:** Tumor lysis syndrome (TLS) is a life-threatening complication that can occur during cancer treatment, particularly in patients with rapidly dividing tumors. It results from the rapid release of cellular components into the bloodstream as tumor cells are destroyed.

**Why the Correct Answer is Right:**

TLS presents with four key features: hyperuricemia, hyperkalemia, hypocalcemia, and hyperphosphatemia. These features are related to the rapid catabolism of tumor cells and the subsequent release of cellular components into the bloodstream.

**Why Each Wrong Option is Incorrect:**

A. Hyperuricemia is a correct feature, as tumor cells can produce uric acid due to their rapid proliferation. However, the other options are incorrect. Hyperkalemia (option B) might occur due to renal impairment or potassium-sparing diuretics, but it is not the primary feature of TLS. Hypocalcemia (option C) can be caused by renal failure, but it is not the primary feature of TLS. Hyperphosphatemia (option D) can occur due to renal impairment, but it is not the primary feature of TLS.

**Clinical Pearl:** Tumor lysis syndrome can lead to acute kidney injury if not diagnosed and treated promptly. Clinicians should be aware of the potential for this complication in patients with rapidly dividing tumors, particularly when initiating chemotherapy.

**Correct Answer:**

. Dysregulated uric acid levels, hyperkalemia, hypocalcemia, and hyperphosphatemia (options A, B, C, and D, respectively) are the primary features of tumor lysis syndrome. These features result from the rapid catabolism of tumor cells and the subsequent release of cellular components into the bloodstream.